Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
Yakult Honsha and Swiss-based Debiopharm International SA said on May 16 that they have filed a lawsuit in Tokyo against Nippon Kayaku, seeking damages over the generic maker’s alleged infringement on their formulation patent for Elplat (oxaliplatin). Yakult Honsha, which…
To read the full story
Related Article
- Nippon Kayaku Notches Top Court Victory for Elplat Damages Suit Too
April 2, 2018
- Nippon Kayaku Prevails in Elplat Damage Suit: High Court
June 30, 2017
- Sawai Prevails in Patent Suit over Elplat
December 26, 2016
- Nichi-Iko Wins Patent Suit over Elplat
November 1, 2016
- Towa Prevails in Patent Suit over Elplat
April 1, 2016
- Debiopharm Wins Elplat Patent Suit against Nippon Kayaku
March 8, 2016
BUSINESS
- Nipro Eyes 50-60 Stemirac Treatment Sites across Japan after Full Nod
November 20, 2026
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- Japan Drug Makers’ Sales Seen Dipping in FY2026 on Co-Marketing Exits
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026





